Literature DB >> 16454877

Quantitative analysis of procalcitonin after pediatric cardiothoracic surgery.

David E Michalik1, Brian W Duncan, Roger B B Mee, Sarah Worley, Johanna Goldfarb, Lara A Danziger-Isakov, Stephen J Davis, A Marc Harrison, Elumalai Appachi, Camille Sabella.   

Abstract

Procalcitonin appears to be an early and sensitive marker of bacterial infection in a variety of clinical settings. The use of levels of procalcitonin to predict infection in children undergoing cardiac surgery, however, may be complicated by the systemic inflammatory response that normally accompanies cardiopulmonary bypass. The aim of our study was to estimate peri-operative concentrations of procalcitonin in non-infected children undergoing cardiac surgery. Samples of serum for assay of procalcitonin were obtained in 53 patients at baseline, 24, 48, and 72 hours following cardiac surgery. Concentrations were assessed using an immunoluminetric technique. Median concentrations were lowest at baseline at less than 0.5 nanograms per millilitre, increased at 24 hours to 1.8 nanograms per millilitre, maximized at 48 hours at 2.1 nanograms per millilitre, and decreased at 72 hours to 1.3 nanograms per millilitre, but did not return to baseline levels. Ratios of concentrations between 24, 48 and 72 hours after surgery as compared to baseline were 6.15, with 95 percent confidence intervals between 4.60 and 8.23, 6.49, with 95 percent confidence intervals from 4.55 to 9.27, and 4.26, with 95 percent confidence intervals between 2.78 and 6.51, respectively, with a p value less than 0.001. In 8 patients, who had no evidence of infection, concentrations during the period from 24 to 72 hours were well above the median for the group. We conclude that concentrations of procalcitonin in the serum increase significantly in children following cardiac surgery, with a peak at 48 hours, and do not return to baseline within 72 hours of surgery. A proportion of patients, in the absence of infection, had exaggerated elevations post-operatively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16454877     DOI: 10.1017/S1047951105002088

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  5 in total

Review 1.  Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature.

Authors:  Christoph Sponholz; Yasser Sakr; Konrad Reinhart; Frank Brunkhorst
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

2.  Procalcitonin Is a Better Biomarker than C-Reactive Protein in Newborns Undergoing Cardiac Surgery: The PROKINECA Study.

Authors:  Sara Bobillo Pérez; Javier Rodríguez-Fanjul; Iolanda Jordan García; Julio Moreno Hernando; Martín Iriondo Sanz
Journal:  Biomark Insights       Date:  2016-11-03

3.  Kinetics of procalcitonin and C-reactive protein and the relationship to postoperative infection in young infants undergoing cardiovascular surgery.

Authors:  Jesse Davidson; Suhong Tong; Amanda Hauck; D Scott Lawson; Eduardo da Cruz; Jon Kaufman
Journal:  Pediatr Res       Date:  2013-07-17       Impact factor: 3.756

4.  Procalcitonin as a biomarker of bacterial infection in pediatric patients after congenital heart surgery.

Authors:  Sujata B Chakravarti; Diane A Reformina; Timothy M Lee; Sunil P Malhotra; Ralph S Mosca; Puneet Bhatla
Journal:  Ann Pediatr Cardiol       Date:  2016 May-Aug

5.  Can acute-phase response biomarkers differentiate infection from inflammation postpediatric cardiac surgery?

Authors:  Bana Agha Nasser; Abdu Rahman Mesned; Mohamad Tageldein; Mohamed S Kabbani; Nada Siddig Sayed
Journal:  Avicenna J Med       Date:  2017 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.